142 related articles for article (PubMed ID: 20213647)
1. In vivo bioassay to detect irinotecan-stabilized DNA/topoisomerase I complexes in rats.
Barth SW; Briviba K; Watzl B; Jäger N; Marko D; Esselen M
Biotechnol J; 2010 Mar; 5(3):321-7. PubMed ID: 20213647
[TBL] [Abstract][Full Text] [Related]
2. Anthocyanins suppress the cleavable complex formation by irinotecan and diminish its DNA-strand-breaking activity in the colon of Wistar rats.
Esselen M; Barth SW; Winkler S; Baechler S; Briviba K; Watzl B; Skrbek S; Marko D
Carcinogenesis; 2013 Apr; 34(4):835-40. PubMed ID: 23275152
[TBL] [Abstract][Full Text] [Related]
3. Structure-based analysis of the effects of camptothecin on the activities of human topoisomerase I.
Champoux JJ
Ann N Y Acad Sci; 2000; 922():56-64. PubMed ID: 11193925
[TBL] [Abstract][Full Text] [Related]
4. DNA topoisomerase I changes the mode of interaction between camptothecin drugs and DNA as probed by UV-resonance Raman spectroscopy.
Feofanov AV; Baranov AV; Fleury F; Riou JF; Nabiev IR; Manfait M
FEBS Lett; 1996 Nov; 396(2-3):289-92. PubMed ID: 8915005
[TBL] [Abstract][Full Text] [Related]
5. Homocamptothecin, an E-ring-modified camptothecin analogue, generates new topoisomerase I-mediated DNA breaks.
Bailly C; Lansiaux A; Dassonneville L; Demarquay D; Coulomb H; Huchet M; Lavergne O; Bigg DC
Biochemistry; 1999 Nov; 38(47):15556-63. PubMed ID: 10569939
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase I-DNA covalent complexes in human colorectal cancer xenografts with different p53 and microsatellite instability status: relation with their sensitivity to CTP-11.
Lansiaux A; Bras-Goncalves RA; Rosty C; Laurent-Puig P; Poupon MF; Bailly C
Anticancer Res; 2001; 21(1A):471-6. PubMed ID: 11299781
[TBL] [Abstract][Full Text] [Related]
7. Detection of topoisomerase inhibitor-induced DNA strand breaks and apoptosis by the alkaline comet assay.
Godard T; Deslandes E; Sichel F; Poul JM; Gauduchon P
Mutat Res; 2002 Sep; 520(1-2):47-56. PubMed ID: 12297143
[TBL] [Abstract][Full Text] [Related]
8. DNA demethylation protects from cleavable complex stabilization and DNA strand breakage induced by the topoisomerase type I inhibitor camptothecin.
Orta ML; Mateos S; Cortés F
Mutagenesis; 2009 May; 24(3):237-44. PubMed ID: 19201781
[TBL] [Abstract][Full Text] [Related]
9. Persistence of camptothecin analog-topoisomerase I-DNA ternary complexes: a molecular dynamics study.
Siu FM; Che CM
J Am Chem Soc; 2008 Dec; 130(52):17928-37. PubMed ID: 19035632
[TBL] [Abstract][Full Text] [Related]
10. Induction of biphasic DNA double strand breaks and activation of multiple repair protein complexes by DNA topoisomerase I drug 7-ethyl-10-hydroxy-camptothecin.
Wu J; Yin MB; Hapke G; Tóth K; Rustum YM
Mol Pharmacol; 2002 Apr; 61(4):742-8. PubMed ID: 11901212
[TBL] [Abstract][Full Text] [Related]
11. Characterization of CPT-11 converting carboxylesterase activity in colon tumor and normal tissues: comparison with p-nitro-phenylacetate converting carboxylesterase activity.
Hennebelle I; Terret C; Chatelut E; Bugat R; Canal P; Guichard S
Anticancer Drugs; 2000 Jul; 11(6):465-70. PubMed ID: 11001387
[TBL] [Abstract][Full Text] [Related]
12. [Homocamptothecins--novel promising anticancer drugs as inhibitors of topoisomerase I].
Yang S; Zhang WN
Yao Xue Xue Bao; 2004 May; 39(5):396-400. PubMed ID: 15338888
[No Abstract] [Full Text] [Related]
13. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
[TBL] [Abstract][Full Text] [Related]
14. Comet assay measures of DNA damage as biomarkers of irinotecan response in colorectal cancer in vitro and in vivo.
Wood JP; Smith AJ; Bowman KJ; Thomas AL; Jones GD
Cancer Med; 2015 Sep; 4(9):1309-21. PubMed ID: 26108357
[TBL] [Abstract][Full Text] [Related]
15. DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
Ling YH; Andersson BS; Nelson JA
Cancer Biochem Biophys; 1990 Jan; 11(1):23-30. PubMed ID: 2159843
[TBL] [Abstract][Full Text] [Related]
16. Eukaryotic DNA topoisomerase I: genome gatekeeper and its intruders, camptothecins.
Pommier Y
Semin Oncol; 1996 Feb; 23(1 Suppl 3):3-10. PubMed ID: 8633251
[TBL] [Abstract][Full Text] [Related]
17. Clinical trials using irinotecan.
Houghton PJ; Santana VM
J Pediatr Hematol Oncol; 2002 Feb; 24(2):84-5. PubMed ID: 11990709
[No Abstract] [Full Text] [Related]
18. DNA strand-breaks induced by the topoisomerase I inhibitor camptothecin in unstimulated human white blood cells.
Daza P; Torreblanca J; García-Herdugo G; Moreno FJ
Cell Biol Int; 2002; 26(8):707-13. PubMed ID: 12175674
[TBL] [Abstract][Full Text] [Related]
19. Luotonin A. A naturally occurring human DNA topoisomerase I poison.
Cagir A; Jones SH; Gao R; Eisenhauer BM; Hecht SM
J Am Chem Soc; 2003 Nov; 125(45):13628-9. PubMed ID: 14599178
[TBL] [Abstract][Full Text] [Related]
20. [The other camptothecins: recent advances with camptothecin analogues other than irinotecan and topotecan].
Lavergne O; Bigg DC
Bull Cancer; 1998 Dec; Spec No():51-8. PubMed ID: 9932086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
